Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
278.25 USD | +0.70% |
|
+0.39% | +18.25% |
1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|
30 | ||||||||
26 | ||||||||
24 | ||||||||
21 | ||||||||
27 | ||||||||
19 | ||||||||
24 | ||||||||
20 | ||||||||
19 | ||||||||
26 | ||||||||
22 | ||||||||
22 | ||||||||
25 | ||||||||
21 | ||||||||
19 | ||||||||
15 | ||||||||
18 | ||||||||
17 | ||||||||
17 | ||||||||
Average | 22 | |||||||
Weighted average by Cap. | 23 |
- Stock Market
- Equities
- ALNY Stock
- Sector Alnylam Pharmaceuticals, Inc.
- Sector revisions

MarketScreener is also available in this country: United States.
Switch edition